Long-term Maintenance Treatment of Restless Legs Syndrome With Gabapentin Enacarbil: A Randomized Controlled Study

Bogan, Richard K.; Bornemann, Michel A. Cramer; Kushida, Clete A.; Trân, Pierre V.; Barrett, Ronald W.
June 2010
Mayo Clinic Proceedings;Jun2010, Vol. 85 Issue 6, p512
Academic Journal
OBJECTIVE: To assess maintenance of efficacy and tolerability of gabapentin enacarbil in patients with moderate to severe primary restless legs syndrome (RLS). PATIENTS AND METHODS: This study (conducted April 18, 2006, to November 14, 2007) comprised a 24-week, single-blind (SB) treatment phase (gabapentin enacarbil, 1200 mg) followed by a 12-week randomized, double-blind (DB) phase. Responders from the SB phase (patients with improvements on the International Restless Legs Scale [IRLS] and investigator-rated Clinical Global Impression-Improvement scale at week 24 and stable while taking a gabapentin enacarbil dose of 1200 mg for at least 1 month before randomization) were randomized to gabapentin enacarbil, 1200 mg, or placebo once daily at 5 pm with food. The primary end point was the proportion of patients experiencing relapse (worse scores on the IRLS and investigator-rated Clinical Global Impression of Change scale on 2 consecutive visits at least 1 week apart or withdrawal because of lack of efficacy) during the DB phase. RESULTS: A total of 221 of 327 patients completed the SB phase, 194 (96 in the gabapentin enacarbil group and 98 in the placebo group) were randomized to DB treatment, and 168 (84 in the gabapentin enacarbil group and 84 in the placebo group) completed the DB phase. A significantly smaller proportion of patients treated with gabapentin enacarbil (9/96 [9%]) experienced relapse compared with the placebo-treated patients (22/97 [23%]) (odds ratio, 0.353; 95% confidence interval, 0.2-0.8; P=.02). Somnolence and dizziness were the most common adverse events. One death occurred (unintentional choking during the SB phase) and was judged as being unrelated to the study drug. No clinically relevant changes were observed in laboratory values, in vital signs, or on electrocardiograms. CONCLUSION: Gabapentin enacarbil, 1200 mg, maintained improvements in RLS symptoms compared with placebo and showed long-term tolerability in adults with moderate to severe primary RLS for up to 9 months of treatment.


Related Articles

  • DOES VALERIAN IMPROVE SLEEPINESS AND SYMPTOM SEVERITY IN PEOPLE WITH RESTLESS LEGS SYNDROME? Cuellar, Norma G.; Ratcliffe, Sarah J. // Alternative Therapies in Health & Medicine;Mar/Apr2009, Vol. 15 Issue 2, p22 

    Objective • To compare the effects of 800 mg of valerian with a placebo on sleep quality and symptom severity in people with restless legs syndrome (RLS). Methods • A prospective, triple-blinded, randomized, placebo-controlled, parallel design was used to compare the efficacy of...

  • Gabapentin improved sensory and motor symptoms in the restless legs syndrome. Garcia-Borreguero, D.; Larrosa, O.; de la Llave, Y. // Evidence Based Medicine;Jul2003, p117 

    The article presents a study that compares the effectiveness of gabapentin than placebo in enhancing the motor and sensory symptoms of restless legs syndrome (RLS) patients in Madrid, Spain. Researchers did a 13-week blinded randomized controlled trial on 24 patients diagnosed for idiopathic RLS...

  • Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study. Goodman, A. D.; Cohen, J. A.; Cross, A.; Vollmer, T.; Rizzo, M.; Cohen, R.; Marinucci, L.; Blight, A. R. // Multiple Sclerosis (13524585);Apr2007, Vol. 13 Issue 3, p357 

    Objective To determine the safety of sustained-release 4-aminopyridine in subjects with mutiple sclerosis (MS) and to examine dose-related efficacy up to 40 mg twice daily. Method Multicenter, randomized, double-blind, placebo-controlled, study. Following a 4-week baseline peroid, subjects were...

  • How to treat tremor: A 1729 opinion. Rektor, Ivan; Rektorová, Irena; Suchý, Václav // Journal of Neurology;May2004, Vol. 251 Issue 5, p525 

    This paper presents an example of 18th century medical thinking. The author, Dr Georg Ernst Stahl (1659–1734) was the founder of the phlogiston theory in the field of chemistry, a medical professor, and a court physician in Saxony and Prussia. His description includes a definition of...

  • Pharma: Clinic Roundup.  // BioWorld Today;5/20/2013, Vol. 24 Issue 96, p7 

    The article discusses the results of a double-blind, placebo-controlled study on the effectiveness of UCB SA's rotigotine transdermal system, Neupro, in reducing total nocturnal systolic blood pressure elevations in patients with idiopathic moderate to severe restless legs syndrome.

  • Preventing Worsening Kidney Function in Patients Receiving Peritoneal Dialysis.  // Annals of Internal Medicine;7/15/2003, Vol. 139 Issue 2, pI-32 

    Kidneys filter out waste products and water from the blood. Many patients who receive dialysis still have some kidney function and some urine production. These patients need less frequent dialysis, may feel healthier, and may live longer than dialysis patients without any kidney function. 60...

  • Efficacy of manual therapy treatments for people with cervicogenic dizziness and pain: protocol of a randomised controlled trial. Reid, Susan A.; Rivett, Darren A.; Katekar, Michael G.; Callister, Robin // BMC Musculoskeletal Disorders;2012, Vol. 13 Issue 1, p201 

    Background: Cervicogenic dizziness is a disabling condition characterised by postural unsteadiness that is aggravated by cervical spine movements and associated with a painful and/or stiff neck. Two manual therapy treatments (Mulligan's Sustained Natural Apophyseal Glides (SNAGs) and Maitland's...

  • Improving delirium care in the intensive care unit: the design of a pragmatic study. Campbell, Noll L; Khan, Babar A; Farber, Mark; Campbell, Tiffany; Perkins, Anthony J; Hui, Siu L; Abernathy, Greg; Buckley, John; Sing, Regg; Tricker, Jason; Zawahiri, Mohammad; Boustani, Malaz A // Trials;2011, Vol. 12 Issue 1, p139 

    Background: Delirium prevalence in the intensive care unit (ICU) is high. Numerous psychotropic agents are used to manage delirium in the ICU with limited data regarding their efficacy or harms.Methods/design: This is a randomized controlled trial of 428 patients aged...

  • Rotigotine Transdermal Patch May Reduce Symptoms and Impact of Restless Legs Syndrome. Greb, Grik // Neurology Reviews;Aug2012, Vol. 20 Issue 8, p17 

    The article presents information on the findings of a study according to which patients with restless legs syndrome (RLS) improved scores on all but one of the items in the International RLS scale by almost the same magnitude. The researchers conducted the study with the intention to treat and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics